科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/18 | 4,395 | 4,577 | 4,373 | 4,561 | +181 | +4.1% | 392,300 |
| 2024/11/15 | 4,386 | 4,398 | 4,316 | 4,380 | +4 | +0.1% | 257,000 |
| 2024/11/14 | 4,369 | 4,420 | 4,310 | 4,376 | +13 | +0.3% | 289,000 |
| 2024/11/13 | 4,330 | 4,448 | 4,302 | 4,363 | +53 | +1.2% | 451,000 |
| 2024/11/12 | 4,093 | 4,318 | 4,093 | 4,310 | +268 | +6.6% | 636,800 |
| 2024/11/11 | 3,939 | 4,075 | 3,935 | 4,042 | +173 | +4.5% | 378,900 |
| 2024/11/08 | 3,906 | 3,909 | 3,751 | 3,869 | -20 | -0.5% | 164,500 |
| 2024/11/07 | 3,885 | 3,919 | 3,883 | 3,889 | +27 | +0.7% | 89,000 |
| 2024/11/06 | 3,890 | 3,905 | 3,861 | 3,862 | -31 | -0.8% | 101,900 |
| 2024/11/05 | 3,885 | 3,901 | 3,873 | 3,893 | +8 | +0.2% | 73,800 |
| 2024/11/01 | 3,900 | 3,918 | 3,871 | 3,885 | -20 | -0.5% | 93,400 |
| 2024/10/31 | 3,922 | 3,933 | 3,885 | 3,905 | +7 | +0.2% | 98,700 |
| 2024/10/30 | 3,925 | 3,945 | 3,891 | 3,898 | -26 | -0.7% | 147,100 |
| 2024/10/29 | 3,887 | 3,953 | 3,887 | 3,924 | +20 | +0.5% | 60,400 |
| 2024/10/28 | 3,892 | 3,912 | 3,874 | 3,904 | +4 | +0.1% | 84,400 |
| 2024/10/25 | 3,901 | 3,908 | 3,870 | 3,900 | +15 | +0.4% | 160,800 |
| 2024/10/24 | 3,852 | 3,899 | 3,840 | 3,885 | +31 | +0.8% | 79,800 |
| 2024/10/23 | 3,848 | 3,892 | 3,840 | 3,854 | -11 | -0.3% | 93,200 |
| 2024/10/22 | 3,870 | 3,872 | 3,833 | 3,865 | -4 | -0.1% | 88,100 |
| 2024/10/21 | 3,861 | 3,871 | 3,838 | 3,869 | +5 | +0.1% | 99,900 |
| 2024/10/18 | 3,889 | 3,922 | 3,853 | 3,864 | +13 | +0.3% | 95,900 |
| 2024/10/17 | 3,842 | 3,859 | 3,827 | 3,851 | +17 | +0.4% | 84,700 |
| 2024/10/16 | 3,869 | 3,907 | 3,834 | 3,834 | -72 | -1.8% | 73,100 |
| 2024/10/15 | 3,881 | 3,907 | 3,865 | 3,906 | +25 | +0.6% | 109,200 |
| 2024/10/11 | 3,900 | 3,905 | 3,873 | 3,881 | -19 | -0.5% | 84,900 |
| 2024/10/10 | 3,880 | 3,914 | 3,880 | 3,900 | -3 | -0.1% | 60,700 |
| 2024/10/09 | 3,885 | 3,911 | 3,874 | 3,903 | +36 | +0.9% | 87,600 |
| 2024/10/08 | 3,850 | 3,891 | 3,839 | 3,867 | -12 | -0.3% | 100,900 |
| 2024/10/07 | 3,890 | 3,890 | 3,851 | 3,879 | +19 | +0.5% | 112,500 |
| 2024/10/04 | 3,840 | 3,875 | 3,840 | 3,860 | -8 | -0.2% | 88,000 |
| 2024/10/03 | 3,863 | 3,879 | 3,831 | 3,868 | +52 | +1.4% | 126,000 |
| 2024/10/02 | 3,827 | 3,870 | 3,812 | 3,816 | -19 | -0.5% | 83,300 |
| 2024/10/01 | 3,823 | 3,846 | 3,776 | 3,835 | +12 | +0.3% | 82,500 |
| 2024/09/30 | 3,779 | 3,837 | 3,770 | 3,823 | -26 | -0.7% | 94,200 |
| 2024/09/27 | 3,880 | 3,895 | 3,840 | 3,849 | -158 | -3.9% | 144,400 |
| 2024/09/26 | 3,980 | 4,007 | 3,968 | 4,007 | +47 | +1.2% | 139,700 |
| 2024/09/25 | 3,916 | 3,970 | 3,899 | 3,960 | +43 | +1.1% | 93,100 |
| 2024/09/24 | 3,949 | 3,957 | 3,908 | 3,917 | -19 | -0.5% | 108,200 |
| 2024/09/20 | 3,904 | 3,960 | 3,904 | 3,936 | +35 | +0.9% | 140,900 |
| 2024/09/19 | 3,910 | 3,952 | 3,901 | 3,901 | -14 | -0.4% | 84,900 |
| 2024/09/18 | 3,910 | 3,946 | 3,882 | 3,915 | -8 | -0.2% | 81,800 |
| 2024/09/17 | 3,965 | 3,974 | 3,893 | 3,923 | -4 | -0.1% | 95,200 |
| 2024/09/13 | 3,958 | 3,958 | 3,900 | 3,927 | -64 | -1.6% | 107,600 |
| 2024/09/12 | 4,000 | 4,033 | 3,967 | 3,991 | +1 | ±0% | 86,700 |
| 2024/09/11 | 4,011 | 4,052 | 3,965 | 3,990 | -44 | -1.1% | 110,700 |
| 2024/09/10 | 4,011 | 4,054 | 4,011 | 4,034 | -11 | -0.3% | 61,800 |
| 2024/09/09 | 4,014 | 4,063 | 4,008 | 4,045 | -18 | -0.4% | 70,100 |
| 2024/09/06 | 4,098 | 4,109 | 4,057 | 4,063 | +6 | +0.1% | 104,400 |
| 2024/09/05 | 4,070 | 4,094 | 4,039 | 4,057 | -20 | -0.5% | 73,800 |
| 2024/09/04 | 4,028 | 4,092 | 4,028 | 4,077 | +39 | +1% | 127,400 |
151～
200
件表示中 / 3732件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 379,100円 | -6.4% | -71.8% | 5.01% | 42.35倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| サンバイオ | 233,200円 | - | - | 0.00% | - | 108.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ジーエヌアイ | 330,000円 | +21.7% | +999.9% | 0.00% | 13.82倍 | 4.57倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 299,700円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
